| PAT. NO. |
Title |
|
7,825,224
|
Product and method for treatment of conditions associated with receptor-desensitization |
|
7,825,089
|
Three-dimensional structures of TALL-1 |
|
7,772,011
|
Method and kit for detection of autoimmune chronic urticaria |
|
7,754,705
|
Cationic steroid antimicrobial compositions and methods of use |
|
7,741,300
|
Methods of using nucleic acid vector-lipid complexes
|
|
7,582,300 |
Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
|
7,534,438
|
Product and process for liquefaction of mucus or sputum |
7,498,047
|
Methods for treatment of thiol-containing compound deficient conditions |
|
7,468,048
|
Joint aspirate facilitating device |
7,374,934
|
Cell populations and methods of production thereof |
|
7,282,477
|
Cystatin C as an antagonist of TGF-.beta. and methods related thereto
|
|
7,189,707
|
Substituted porphyrins |
7,169,570
|
Method to identify regulators of cellular activation using Bcl10
|
|
7,160,681
|
Method for regulating cell growth and assays related thereto |
|
7,090,865
|
Composition and method for treating autoimmune hemolytic anemia |
|
6,951,733
|
Method for testing drug susceptibility of Mycobacterium tuberculosis |
|
6,916,799
|
Substituted Porphyrins |
|
6,875,749
|
Methods for facilitating vascular growth |
|
6,737,398
|
Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
|
6,693,086
|
Systemic immune activation method using nucleic acid-lipid complexes |
|
6,579,694
|
Agar medium for the growth of Mycobacterium tuberculosis |
|
6,576,433
|
Method for identification of cell growth or differentiation factors |
|
6,555,318
|
Method for identification of cell growth or differentiation factors |
|
6,544,975
|
Substituted porphyrins |
|
6,503,509
|
Method for receptor desensitization |
|
6,497,840
|
Ultraviolet germicidal system |
|
6,479,477
|
Substituted porphyrins |
|
6,475,987
|
Tall-1 receptor homologues |
|
6,399,607
|
Aminomethylene amide analogs of pyrazinamide with intracellular antimycobacterial activity against pyrazinamide-resistant mycobacteria combined with a rifamycin |
|
6,333,170
|
Method and product for regulating cell responsiveness to external signals |
|
6,306,612
|
Methods of facilitating vascular growth |
|
6,264,888
|
Ultraviolet germicidal apparatus and method |
|
6,231,894
|
Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
|
6,187,584
|
Products and processes for regulation of gene recombination |
|
6,156,503
|
Diagnosing asthma patients predisposed to adverse .beta.-agonist reactions |
|
6,110,739
|
Method to produce novel embryonic cell populations |
|
6,074,861
|
MEKK proteins |
|
6,040,152
|
Method and assay for regulation of T cell proliferation |
|
5,985,261
|
Use of thioredoxin-like molecules for induction of MnSOD to treat oxidative damage |
|
5,981,265
|
Methods for regulating MEKK protein activity |
|
5,959,074
|
Products and processes for regulation of gene recombination |
|
5,935,568
|
Gene therapy for effector cell regulation |
|
5,914,268
|
Embryonic cell populations and methods to isolate such populations |
|
5,874,301
|
Embryonic cell populations and methods to isolate such populations |
|
5,820,866
|
Product and process for T cell regulation |
|
5,405,941
|
MEKK protein, capable of phosphorylating MEK |
